• Monte Rosa Therapeutics filed a Form 4 reporting Chief Scientific Officer Sharon Townson’s July 6, 2026 change in beneficial ownership.
• Townson exercised stock options for 6,000 shares at USD 6.14.
• She sold 6,000 shares at prices of about USD 23.25 and USD 24.13.
• Her direct holdings ended at 67,845 shares.
• She reported 197,290 stock options outstanding following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monte Rosa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-297558), on July 07, 2026, and is solely responsible for the information contained therein.